WIRE — The Ministry of Health and Sanitation will from 1 July 2026 roll out Lenacapavir (LEN), a long-acting injectable HIV prevention drug given once every six months. The medicine is intended for HIV-negative people at substantial risk of HIV infection, offering an additional prevention option alongside existing methods. The official launch will be held at Area
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.